Moreover, a Ki67 staining assay showed a trend indicating an increased proliferation of CD8+ T cells in NB tumors of mice treated with the β3-AR antagonist or PD-L1 antibody, even if it failed to reach significant differences (Fig. 4C). The gene discussed is CD8A; the disease is neuroblastoma.